Lightpoint gets CE Mark for Sensei device

2021 01 20 18 57 8889 2021 01 19 Lightpoint 20210120182108

Luminescence imaging technology developer Lightpoint Medical has received a CE Mark for Sensei, the first robotic gamma probe to be commercially available in Europe.

Lightpoint Medical's Sensei device. Image courtesy of Lightpoint.Lightpoint Medical's Sensei device. Image courtesy of Lightpoint.

Sensei is designed for the intraoperative detection of sentinel lymph nodes and cancer metastasis throughout the lymphatic system. The device aims to provide more precise, targeted cancer surgery and is applicable for major cancer types, including lung, colorectal, stomach, gynecological, and prostate cancer.

Page 1 of 543
Next Page